Purple Biotech Ltd. (PPBT) NASDAQ
3.01
+0.02(+0.67%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.01
+0.02(+0.67%)
Currency In USD
| Market Cap | 15,768 |
| Enterprise Value | -8.46M |
| P/E Ratio | -0.25 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.66 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.48 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.79 |
| Return On Equity | -1.23 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -26.25M |
| Net Income | -26.39M |
| Diluted EPS | -11,080 |
| Total Cash | 6.43M |
| Total Cash/Share | 0 |
| Total Debt | 184,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 1.48 |
| Book Value Per Share | 0.01 |
| 52-Week Change | -88.91 |
| 52-Week High | 29 |
| 52-Week Low | 2.52 |
| Moving Average 50 Days | 3.94 |
| Moving Average 200 Days | 6.75 |
| Average Volume | 115,933 |
| Shares Outstanding | 138,084 |
| % Held by Institutions | 3,151.99 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | March 02, 2026 |